SG3 Management’s BioTelemetry, Inc. BEAT Stock Holding History

SG3 Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,700	Closed	-$123K	–	1321
2020 Q3	$123K	Buy	+2,700	New	+$113K	﹤0.01%	775

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

SG3 Management's BEAT Position: Q4 2020 in Review

SG3 Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 2,700 shares — an estimated $123K sold.

SG3 Management first reported a position in BEAT in Q3 2020 and held it in 1 quarter. The position peaked at $123K in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

SG3 Management reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
SG3 Management sold 2,700 BioTelemetry, Inc. shares in Q4 2020, an estimated $123K.
SG3 Management first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 1 quarter.
SG3 Management's BioTelemetry, Inc. position peaked at $123K in Q3 2020.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on SG3 Management's 13F filing for Q4 2020, filed 16 Feb 2021.